| Kayce Lefevre, AG-PCNP | |
|
1221 Lee St, Charlottesville, VA 22908-7760 | |
| (434) 243-1000 | |
| (434) 244-7551 |
| Full Name | Kayce Lefevre |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Gerontology |
| Location | 1221 Lee St, Charlottesville, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629436324 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 0024178415 (Virginia) | Secondary |
| 363LG0600X | Nurse Practitioner - Gerontology | 0024178415 (Virginia) | Primary |
| Entity Name | University Of Virginia Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033138250 PECOS PAC ID: 4880590728 Enrollment ID: O20040102000780 |
News Archive
Omega Protein Corporation, a nutritional ingredient company and the nation's leading vertically integrated producer of omega-3 fish oil and specialty fish meal products, today reported financial results for the fourth quarter and full year ended December 31, 2011.
The Office for Victims of Crime (OVC), in the Department of Justice's Office for Justice Programs, plans to award up to $750,000 over three years in funding dedicated to helping American victims of domestic violence overseas. This is the first year OVC awarded the funding.
A new decontamination agent devised by US chemists can deactivate toxic chemicals such as nerve agents and pesticides - leaving only non-toxic, easily disposable by-products, according to research in the New Journal of Chemistry.
Inspiration Biopharmaceuticals, Inc. today announced the initiation of patient enrollment in the second of two pivotal studies in the Company's OBI-1 Accur8 clinical trial program.
› Verified 2 days ago
| Entity Name | Cardiology Associates Of Fredericksburg, Ltd. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487748240 PECOS PAC ID: 8325141609 Enrollment ID: O20070312000343 |
News Archive
Omega Protein Corporation, a nutritional ingredient company and the nation's leading vertically integrated producer of omega-3 fish oil and specialty fish meal products, today reported financial results for the fourth quarter and full year ended December 31, 2011.
The Office for Victims of Crime (OVC), in the Department of Justice's Office for Justice Programs, plans to award up to $750,000 over three years in funding dedicated to helping American victims of domestic violence overseas. This is the first year OVC awarded the funding.
A new decontamination agent devised by US chemists can deactivate toxic chemicals such as nerve agents and pesticides - leaving only non-toxic, easily disposable by-products, according to research in the New Journal of Chemistry.
Inspiration Biopharmaceuticals, Inc. today announced the initiation of patient enrollment in the second of two pivotal studies in the Company's OBI-1 Accur8 clinical trial program.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kayce Lefevre, AG-PCNP Po Box 9007, Charlottesville, VA 22906-9007 Ph: () - | Kayce Lefevre, AG-PCNP 1221 Lee St, Charlottesville, VA 22908-7760 Ph: (434) 243-1000 |
News Archive
Omega Protein Corporation, a nutritional ingredient company and the nation's leading vertically integrated producer of omega-3 fish oil and specialty fish meal products, today reported financial results for the fourth quarter and full year ended December 31, 2011.
The Office for Victims of Crime (OVC), in the Department of Justice's Office for Justice Programs, plans to award up to $750,000 over three years in funding dedicated to helping American victims of domestic violence overseas. This is the first year OVC awarded the funding.
A new decontamination agent devised by US chemists can deactivate toxic chemicals such as nerve agents and pesticides - leaving only non-toxic, easily disposable by-products, according to research in the New Journal of Chemistry.
Inspiration Biopharmaceuticals, Inc. today announced the initiation of patient enrollment in the second of two pivotal studies in the Company's OBI-1 Accur8 clinical trial program.
› Verified 2 days ago